Posted in | News | Plastics and Polymers | Nanomaterials and Nanotechnology | Business

Lockheed Martin to Purchase Electro-Optic Activity Materials from Lumera Corp

Mar 13 2007

Lumera Corporation, a leader in the emerging field of nanotechnology, announced that it had received a purchase order from Lockheed Martin for Lumera's high electro-optic activity materials. The term of the agreement is until December 31, 2007, at which time Lockheed Martin will advise Lumera of its intentions regarding a commercial license for the materials.

"We are pleased that Lockheed Martin is interested in our polymer materials and expect that the materials will perform as anticipated," said Dr. Raluca Dinu, Director of Lumera's Electro-Optic Business Unit. "We look forward to developing a long-term relationship with Lockheed Martin.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback